Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 866.67M | 764.38M | 684.26M | 648.07M | 508.84M |
Gross Profit | 234.62M | 218.94M | 244.19M | 224.28M | 166.54M |
EBITDA | -35.72M | -46.04M | 658.00K | 81.80M | 108.73M |
Net Income | -93.46M | -104.75M | -75.33M | -65.20M | -29.40M |
Balance Sheet | |||||
Total Assets | 793.84M | 810.91M | 977.31M | 1.29B | 1.53B |
Cash, Cash Equivalents and Short-Term Investments | 52.50M | 44.32M | 71.88M | 80.57M | 258.84M |
Total Debt | 456.40M | 451.27M | 512.44M | 565.59M | 690.74M |
Total Liabilities | 579.32M | 588.35M | 650.00M | 887.41M | 1.06B |
Stockholders Equity | 214.52M | 222.56M | 327.31M | 402.64M | 467.84M |
Cash Flow | |||||
Free Cash Flow | -34.23M | 55.42M | -4.98M | -156.86M | -21.57M |
Operating Cash Flow | 31.53M | 88.64M | 15.46M | -135.29M | -12.47M |
Investing Cash Flow | -65.54M | -32.89M | 55.94M | 113.42M | 300.93M |
Financing Cash Flow | 42.19M | -83.31M | -80.09M | -156.41M | -54.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | HK$1.75B | 8.52 | 12.91% | 5.06% | 9.63% | 20.08% | |
77 Outperform | HK$944.10M | 7.54 | 5.39% | 14.35% | -1.88% | 129.25% | |
71 Outperform | HK$335.00M | 9.08 | 8.18% | 0.67% | >-0.01% | 16.04% | |
68 Neutral | HK$415.00M | 7.03 | 5.59% | 10.00% | 4.97% | -16.24% | |
66 Neutral | $906.12M | 39.60 | 1.74% | 1.81% | -0.82% | ― | |
60 Neutral | HK$17.56B | 11.08 | 0.20% | 5.34% | 2.68% | -48.29% | |
42 Neutral | HK$476.15M | ― | -42.82% | ― | 10.98% | 29.31% |
Labixiaoxin Snacks Group Ltd. announced that all ordinary resolutions proposed at their Annual General Meeting on June 19, 2025, were passed unanimously. This includes the adoption of financial statements, re-election of directors, and granting a mandate to issue shares, reflecting strong shareholder support and potentially impacting the company’s strategic operations and market positioning positively.
Labixiaoxin Snacks Group Ltd. has revised the terms of reference for its Nomination Committee, emphasizing a structure that includes a majority of independent non-executive directors and gender diversity among its members. This move is aimed at enhancing governance and ensuring diverse perspectives in decision-making, potentially impacting the company’s strategic direction and stakeholder confidence.
Labixiaoxin Snacks Group Ltd. announced a change in the composition of its Nomination Committee, with Ms. Wu Qiongyao replacing Mr. Zheng Yu Shuang as a member, effective June 19, 2025. This change aligns with amendments to the Listing Rules and Corporate Governance Code, aiming to enhance the board’s effectiveness and diversity, thereby improving the company’s corporate governance practices.
Labixiaoxin Snacks Group Ltd. has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to the audit, nomination, and remuneration committees. This announcement provides clarity on the governance structure, potentially impacting the company’s strategic direction and stakeholder confidence.
Labixiaoxin Snacks Group Ltd. has announced its upcoming annual general meeting scheduled for June 19, 2025, in Hong Kong. Key agenda items include the adoption of financial statements for 2024, re-election of directors, and authorization for the board to fix remuneration for directors and auditors. The meeting will also consider resolutions to empower directors to manage share-related activities, which could impact the company’s capital structure and shareholder value.